ICM – Institut du Cerveau et de la Moelle épinière (Brain and Spine Institute) – is an internationally
renowned Neuroscience research institute located in Paris, France, on the campus of the Pitié-
Salpêtrière hospital, providing world class expertise in basic and clinical neuroscience.

ICM is seeking to recruit a group leader in the field of in silico biomarker analysis in Alzheimer’s
disease (AD) and related dementias. The successful candidate will work in close interaction with
ICM scientists and clinicians of the “Institute for Memory and Alzheimer Disease” (IM2A) at the
Pitié-Salpêtrière Hospital.

We welcome applications from early to mid-career investigators with a strong scientific track
record in translational research. We are particularly interested in candidates whose research may
concern biomarkers of AD and related dementias, multimodal data integration, or in silico disease

The successful candidate will benefit from a competitive start-up package, including the permanent
AXA-Chair and a funding from Merck-Avenir Foundation, both dedicated to biomarkers of
Alzheimer, space and recurrent core funding. Candidates will work in a stimulating and
collaborative international environment with a facilitated access to well-structured cohorts in the
field of neurodegenerative diseases. Group leaders at the ICM are affiliated with the Neuroscience
Ph.D. program of the Sorbonne Université. Skilled assistance for applications to national and
international funding programs will be also provided (e.g. ERC, CNRS, Inserm, ANR, ATIP-Avenir,
Equipes FRM).

ICM is home to 25 research teams bringing together more than 700 personnel, including 150
researchers, 200 technical staff and 300 students and post-docs. ICM laboratories use multiscale
approaches from cellular and molecular neurobiology, neurophysiology, systems to cognitive
neuroscience. ICM offers state-of the-art core facilities that support fundamental, preclinical and
clinical research, including access to human tissue.

ICM is a private foundation working in synergy with French public bodies, and affiliated with
Sorbonne Université, CNRS and INSERM. Importantly, ICM is associated with the Medical University
Department (DMU) for the Diseases of the Nervous System of the Pitié-Salpêtrière hospital (APHP),
as well as with a large network of public and industrial partners. ICM is dedicated to fundamental,
translational and clinical research in Neuroscience, and fosters improved quality of care and
education. Moreover, it hosts an in-house neuroscience clinical research center, spinoff, start-ups
2 companies. ICM is located alongside 13 National Reference Centers at the Pitié-Salpêtrière for rare
neurological diseases.

Expression of interest must include a 2-page CV, a complete list of publications highlighting up to
five of the most significant papers, a brief description of achievements and future research (2
pages). Applications must be sent by January 15th 2020 to Dr. Alexandra Auffret at the following
address: scientific.affairs@icm-institute.org

Short-listed applicants will be requested to send the full application proposal (attached file)
– Project title and summary and a list of up to five of the candidate’s most significant publications
(limited 2 pages)
– Full CV including list of publications and invited presentations to conferences
– Description of the research project (no more than 10 pages)
– Names and contacts of at least three referees
Full applications must be sent by April 30th 2020 at the following address scientific.affairs@icminstitute.

All applications will be reviewed by members of the Scientific Advisory Board of the institute and
international experts in the field. Short-listed applicants will be invited for an interview and oral
presentation in Paris in June 2020.